PubAg

Main content area

Simultaneous Deficiency in CD28 and STAT6 Results in Chronic Ectoparasite-Induced Inflammatory Skin Disease

Author:
Liu, Qian, Arseculeratne, Cristin, Liu, Zhugong, Whitmire, Jeannette, Grusby, Michael J., Finkelman, Fred D., Darling, Thomas N., Cheever, Allen W., Swearengen, James, Urban, Joseph F., Gause, William C.
Source:
Infection and immunity 2004 v.72 no.7 pp. 3706
ISSN:
1098-5522
Subject:
Demodex, ectoparasites, parasitoses, skin diseases, inflammation, mutants, transcription factors, lymphocyte antigens, CD4-positive T-lymphocytes, dermatitis, host-parasite relationships, nematode infections, Nippostrongylus brasiliensis, interleukin-4, immunoglobulin G, antibody formation, CD8-positive T-lymphocytes, mice
Abstract:
A mouse lacking CD28, a T-cell costimulatory molecule, and STAT6, a transcription factor that mediates interleukin-4 (IL-4) signaling, was developed from parental CD28- and STAT6-deficient mice. STAT6/CD28-/- BALB/c mice that were 8 weeks old had a normal phenotype, and IL-4 production was induced following infection with nematode parasites. Unexpectedly, when they were between 4 and 8 months old, all mice examined spontaneously developed severe chronic dermatitis associated with pronounced numbers of Demodex ectoparasites. In addition, pronounced CD4 and CD8 T-cell infiltrates in the dermis and subcutaneous fat, increased serum immunoglobulin G2a levels, and lymphadenopathy associated with increased gamma interferon and IL-12 expression were observed. Single-knockout siblings lacking either CD28 or STAT6 had a phenotype similar to that of BALB/c wild-type controls. To distinguish whether the ectoparasite Demodex or the Th1 immunity was the proximal cause of the inflammatory skin disease, STAT6/CD28-/- mice were treated with a miticide that eliminated the ectoparasites. This treatment markedly reduced the severity of the dermatitis and the associated lymphoid infiltrates. These findings suggest that ubiquitous ectoparasites, which are generally considered to be commensal, may contribute to disease when specific molecules required for an effective Th2 response are blocked.
Agid:
42561
Handle:
10113/42561